1. Home
  2. SKYE vs BSBK Comparison

SKYE vs BSBK Comparison

Compare SKYE & BSBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SKYE
  • BSBK
  • Stock Information
  • Founded
  • SKYE 2012
  • BSBK 1893
  • Country
  • SKYE United States
  • BSBK United States
  • Employees
  • SKYE N/A
  • BSBK N/A
  • Industry
  • SKYE Biotechnology: Pharmaceutical Preparations
  • BSBK Banks
  • Sector
  • SKYE Health Care
  • BSBK Finance
  • Exchange
  • SKYE Nasdaq
  • BSBK Nasdaq
  • Market Cap
  • SKYE 108.3M
  • BSBK 105.4M
  • IPO Year
  • SKYE N/A
  • BSBK N/A
  • Fundamental
  • Price
  • SKYE $4.12
  • BSBK $8.21
  • Analyst Decision
  • SKYE Buy
  • BSBK
  • Analyst Count
  • SKYE 6
  • BSBK 0
  • Target Price
  • SKYE $18.67
  • BSBK N/A
  • AVG Volume (30 Days)
  • SKYE 166.3K
  • BSBK 5.8K
  • Earning Date
  • SKYE 11-07-2024
  • BSBK 11-01-2024
  • Dividend Yield
  • SKYE N/A
  • BSBK N/A
  • EPS Growth
  • SKYE N/A
  • BSBK N/A
  • EPS
  • SKYE N/A
  • BSBK N/A
  • Revenue
  • SKYE N/A
  • BSBK $12,432,417.00
  • Revenue This Year
  • SKYE N/A
  • BSBK N/A
  • Revenue Next Year
  • SKYE N/A
  • BSBK N/A
  • P/E Ratio
  • SKYE N/A
  • BSBK N/A
  • Revenue Growth
  • SKYE N/A
  • BSBK N/A
  • 52 Week Low
  • SKYE $1.44
  • BSBK $6.40
  • 52 Week High
  • SKYE $19.41
  • BSBK $8.66
  • Technical
  • Relative Strength Index (RSI)
  • SKYE 35.19
  • BSBK 53.85
  • Support Level
  • SKYE $4.32
  • BSBK $7.86
  • Resistance Level
  • SKYE $5.67
  • BSBK $8.24
  • Average True Range (ATR)
  • SKYE 0.49
  • BSBK 0.23
  • MACD
  • SKYE -0.17
  • BSBK -0.01
  • Stochastic Oscillator
  • SKYE 2.65
  • BSBK 79.09

About SKYE Skye Bioscience Inc. Common Stock

Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.

About BSBK Bogota Financial Corp.

Bogota Financial Corp is a New Jersey-based bank. It offers personal and business banking services such as savings, certificates of deposits, online banking, loans, and many more. The Bank generally grants residential, commercial, and consumer loans to, and accepts deposits from, customers in New Jersey.

Share on Social Networks: